Strong AI momentum masks execution delays, guidance held despite record bookings

AI growth credible; overall company YoY 2.6% constant currency suggests AI at ~5% of revenue but growing from small base

Strong pipeline confirmed; but mega deal ramps only April 2027 with negligible FY27 revenue impact as stated

Q1 reported 16.9%, adjusted 17.5% (after 62 bps restructuring); at lower end of band; prior year adjusted was 17.7% (margin compression YoY ex-restructuring)

Delivered growth 13.9% INR (includes 2.6% CC + currency). ITBS growth confirmed but ERS at only 0.3% YoY masks weakness

ERS -3.7% QoQ, +0.3% YoY; management acknowledges headwind will persist—real near-term risk to guidance

Prior FY27 guidance: 1-4% organic growth, 17.5-18.5% margin. Current call: identical band reaffirmed despite $2.4B Q1 bookings (highest ever). Suggests management caution on macro/ramp-up or desire to under-promise.

INR3,500 Cr initial capex for 50MW AI datacenter capacity; targets SLM training and sovereign AI. Long-term ambition but unproven execution; competes with core services for capital.

ERS now +0.3% YoY (vs historical higher-single-digit growth). Large US telco discretionary cuts explicitly flagged to persist; prior quarter hinted at 'subsequent quarter impact'—now confirmed in Q1 and expected to continue.

5 pillars now mature (AI Force at 92 clients, 23 industry AI solutions, Sarvam partnership, sovereign AI, talent at scale). Advanced AI now $171M (+62% YoY). New vector vs prior call.

Strong booking but guidance band broader; only first quarter; mega deal ramp starts in months, steady-state April 2027, negligible FY27 impact. Will review after Q2.

INR3,500 Cr is initial fraction, not full 50MW cost. Full-stack play (not colo), partner funding mix, disciplined investment from FCF. SLM focus, outcome-based contracts bundled capacity.

Token costs emerged as topic with enterprise scaling. Tiered approach (private SLMs + frontier via gateway) most popular for cost and sovereignty. Costs may drop but consumption rises; SLM training is services opportunity.

Yes, potential with global enterprises for tiered approach. Sarvam strong partnership but model dependency not required; other options exist but Sarvam closer partnership aids execution.

FY27 guidance 17.5-18.5% includes ~40-50 bps restructuring cost. Last year ex-restructuring ~18%. FY28 guidance deferred to next year guidance call. Focus on this year.

Tech, Telecom, Media & Entertainment verticals. Large US telcos sharp discretionary spend cuts flagged last quarter, now playing out. Strong tech base, prior quarters momentum masks it.

Closed models have limitations. Open models (weight, source) preferred. Our play full-stack SLM + services, not raw gigawatt capacity. 50MW sufficient for SLM, higher margin per MW than hyperscale.

Yes, guidance improving gross margins. If strategy works, gross margin per employee rises. Will invest as business at inflection; expect greater client value.

High-level economics correct. Did NOT say INR3,500 Cr for 50MW. Starting INR3,500 Cr, fraction capacity. Partner funding (silicon, OEM, committed contracts), equity/debt mix. Not investing INR30,000 Cr. Disciplined from FCF.

Market heavily GPU-starved today. Big companies rent GPU capacity because lucrative. 50MW tiny fraction needed. Capacity consumed very quickly including initial commitments. Next investments based on initial delivery.

Big reversal. Private AI stack answers enterprise needs. Data sensitivity, price performance attractive for SLM. Can use VPN with cloud but private/on-prem better. Cycle looks different.

Happy Q1 better than expected. Macro and client-specific challenges from last quarter continue as planned. Macro situation same as March; no visibility to change. Continue guidance; review after Q2.

Revenue and margin guidance for organic business. M&A impact (Jaspersoft, other) separate. Guidance does not include M&A margin/revenue impact.

Solid momentum 12 quarters, highest YoY growth in industry. Driven by AI-native approach to large clients, proactive AI adoption, wallet share wins. Broad-based traction in data/analytics (preparatory work for enterprise AI stack).

Strong regulatory work for medical device companies 3 years ago ended, not refilled. Healthcare segment stressed in US; most revenue from US. Two headwinds. Continue to win but facing headwinds.

Correct, Q2 onwards. Range $10-15M per quarter estimated (seasonality involved). CTG expected close late Q2 (maybe later part of quarter).

Q1 delivered 2.6% YoY CC, comfortably within range but at low end. Maintained despite record Q1 bookings ($2.4B) suggests caution on macro and booking ramp-up timelines. Mega deal (early July) contributes negligibly to FY27.

Q1 adjusted margin 17.5% (16.9% reported + 62 bps restructuring), at lower end of band. Prior year adjusted ~17.7%, signaling margin compression YoY. Guidance maintained despite margin headwinds (seasonality, ERS decline, AI investments).

Management emphasizes 'initial' investment and 'fraction' of 50MW vision. Disciplined phased approach based on FCF; partner funding (silicon/OEM) to be pursued; equity/debt mix. No clear upper bound or timeline for full 50MW.

ERS +0.3% YoY (vs historical 4-6%+) due to two large US telco discretionary spend cuts. Software -5.3% YoY. Together offset ITBS +4.2% YoY and BFSI strength. Expected to persist through FY27, capping growth to low end of guidance.

Q1 adjusted margin 17.5%, down from Q4 17.7% and prior year ~18%. Guidance band 17.5-18.5% requires 100 bps improvement by year-end. Annual productivity benefits and ERS decline offset restructuring savings and forex tailwind. AI investments may continue margin pressure.

INR3,500 Cr initial investment for unproven 50MW AI datacenter business with SLM focus. Management cites full-stack play (not pure colo) and partner funding but lacks clear technical/commercial roadmap. Capex could absorb FCF ($1.98B LTM) and constrain dividends (current payout 93.2% of income). Demand cycle risk (compute scarcity may not materialize as expected).

Two large US telcos cutting discretionary ER&D spending (no quantified exposure but acknowledged as 'sharp cuts'). Europe near-flat (+0.1% YoY) signals caution. Customer concentration risk in ERS suggests high dependency on select customers; loss or further cuts would materially impact ERS and overall guidance.

Advanced AI $171M represents ~5% of $3,650M total revenue (estimated). While 62% YoY growth impressive, absolute contribution modest. Risk of market overvaluation of AI impact if booking-to-revenue cycle slows or client implementation stalls.